OC-0425 Clinical experience with stereotactic MR- guided adaptive radiation therapy for pancreatic tumors

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Purpose or Objective The duodenum is the primary dose-limiting organ when performing SBRT for locally advanced pancreatic cancer (LAPC). With technical and imaging advancements, the incidence of grade ≥3 small bowel toxicity (bleeding, perforation, strictures) has decreased to
Original languageEnglish
Pages (from-to)S224-S225
JournalRadiotherapy and Oncology
Volume123
DOIs
Publication statusPublished - 2017

Cite this

@article{d3cef7ddea024ce2ae3233416e8ef081,
title = "OC-0425 Clinical experience with stereotactic MR- guided adaptive radiation therapy for pancreatic tumors",
abstract = "Purpose or Objective The duodenum is the primary dose-limiting organ when performing SBRT for locally advanced pancreatic cancer (LAPC). With technical and imaging advancements, the incidence of grade ≥3 small bowel toxicity (bleeding, perforation, strictures) has decreased to",
author = "A Bruynzeel and F Lagerwaard and O Bohoudi and S Tetar and N Haasbeek and Oei, {S S} and B Slotman and M Meijerink and S Senan and M. Palacios",
year = "2017",
doi = "10.1016/s0167-8140(17)30867-8",
language = "English",
volume = "123",
pages = "S224--S225",
journal = "Radiotherapy and Oncology",
issn = "0167-8140",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - OC-0425 Clinical experience with stereotactic MR- guided adaptive radiation therapy for pancreatic tumors

AU - Bruynzeel, A

AU - Lagerwaard, F

AU - Bohoudi, O

AU - Tetar, S

AU - Haasbeek, N

AU - Oei, S S

AU - Slotman, B

AU - Meijerink, M

AU - Senan, S

AU - Palacios, M.

PY - 2017

Y1 - 2017

N2 - Purpose or Objective The duodenum is the primary dose-limiting organ when performing SBRT for locally advanced pancreatic cancer (LAPC). With technical and imaging advancements, the incidence of grade ≥3 small bowel toxicity (bleeding, perforation, strictures) has decreased to

AB - Purpose or Objective The duodenum is the primary dose-limiting organ when performing SBRT for locally advanced pancreatic cancer (LAPC). With technical and imaging advancements, the incidence of grade ≥3 small bowel toxicity (bleeding, perforation, strictures) has decreased to

U2 - 10.1016/s0167-8140(17)30867-8

DO - 10.1016/s0167-8140(17)30867-8

M3 - Article

VL - 123

SP - S224-S225

JO - Radiotherapy and Oncology

JF - Radiotherapy and Oncology

SN - 0167-8140

ER -